For this, we have previously discovered new cell surface biomarkers, a carcinoembryonic antigen-associated cell adhesion molecule 6 (CEACAM6 or CD66c), of breast cancer-derived cancer stem cells (BCSCs) through omics-based analysis, which is the first report of its function in BCSCs [23]. The gene discussed is CEACAM6; the disease is breast carcinoma.